The Global Pharmacogenomics Market size is expected to reach $9.9 billion by 2025, rising at a market growth of 8.8% CAGR during the forecast period
NEW YORK, July 15, 2019 /PRNewswire/ -- The Global Pharmacogenomics Market size is expected to reach $9.9 billion by 2025, rising at a market growth of 8.8% CAGR during the forecast period.
Download the full report: https://www.reportbuyer.com/product/5795801/?utm_source=PRN
Pharmacogenomics or personalized medicine is defined as "the tailoring of medical treatment to the specific characteristics of each patient." This concept, in reality, involves the ability to classify individuals into sub-populations which are disproportionately susceptible to a particular disease or responsive to a particular treatment. Personalized medicine emphasizes on the paradigm shift in medicine from reaction to prevention. The individual response to the drug varies according to the genetic composition. Most of the responses are positive and show improvement while few face the side effects. To address those variations, it is necessary to study how the drug processing is affected by the genes. So when the genetic variation is affecting the drug processing and response, there is the scope of the clinical study to be conducted and based on the result, adjust the dosage or to find a different drug according to the genetic composition of an individual.
Increase in the geriatric population, growing adoption of pharmacogenomics procedure by healthcare professionals, increased awareness of patients towards personalized therapy, and the emerging prevalence of chronic diseases like cancer, tuberculosis, HIV, and others, are driving the growth of pharmacogenomics market.
Based on Technology, the market is segmented into Sequencing, Polymerase Chain Reaction, Electrophoresis, Mass Spectrometry, Microarray and Others. Based on Application, the market is segmented into Oncology, Psychiatry, Infectious Diseases, Neurological Diseases, Pain management, Cardiovascular Diseases and Others. Based on End User, the market is segmented into Hospitals and Clinics, Research Institutions, and Academic Institutes. The hospitals and clinics segment accounted for the largest share among end users for pharmacogenomic products, followed by research organizations and academic institutes. This is attributed to the fact that hospitals are well-equipped with molecular diagnostic lab units to cater to the different needs of the patients. Moreover, pharmacogenomics lab units at hospitals are well-equipped with highly superior systems. Based on Regions, the market is segmented into North America, Europe, Asia Pacific, and Latin America, Middle East & Africa.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Empire Genomics LLC, Illumina, Inc., oneome LLC, Myriad Genetics Inc., Thermo Fisher Scientific, Inc., Teva Pharmaceuticals Industries Ltd., Bayer AG, Opko Health, Inc., and Becton, Dickinson and Company.
Scope of the Study
Market Segmentation:
By Application
-- Sequencing
-- Polymerase Chain Reaction
-- Electrophoresis
-- Mass Spectrometry
-- Microarray
-- Others
By Application
-- Oncology
-- Psychiatry
-- Infectious Diseases
-- Neurological Diseases
-- Pain management
-- Cardiovascular Diseases
-- Others
By End User
-- Hospitals and Clinics
-- Research Institutions
-- Academic Institutes
By Geography
-- North America
o US
o Canada
o Mexico
o Rest of North America
-- Europe
o Germany
o UK
o France
o Russia
o Spain
o Italy
o Rest of Europe
-- Asia Pacific
o China
o Japan
o India
o South Korea
o Singapore
o Malaysia
o Rest of Asia Pacific
-- LAMEA
o Brazil
o Argentina
o UAE
o Saudi Arabia
o South Africa
o Nigeria
o Rest of LAMEA
Companies Profiled
-- Abbott Laboratories
-- Empire Genomics LLC
-- Illumina, Inc.
-- Oneome LLC
-- Myriad Genetics Inc.
-- Thermo Fisher Scientific, Inc.
-- Teva Pharmaceuticals Industries Ltd.
-- Bayer AG
-- Opko Health, Inc.
-- Becton, Dickinson and Company
Download the full report: https://www.reportbuyer.com/product/5795801/?utm_source=PRN
About Reportbuyer
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers
For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: sarah@reportbuyer.com
Tel: +1 (718) 213 4904
Website: www.reportbuyer.com
SOURCE ReportBuyer
